Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 safety study of a measles-rubella vaccine in healthy adult men
RBR-9hckj4Phase 1Completed
- Sponsor
- Bio-Manguinhos
- Start
- Sep 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Measles and Rubella Vaccine (PT Bio Farma) in measles and rubella, sponsored by Bio-Manguinhos. Primary endpoint: Safety and adverse reactions. Started Sep 2015; status: completed.
02
Drugs
Measles and Rubella Vaccine (PT Bio Farma)
03
Conditions
measlesrubella
Beyond the preview
Go deeper on RBR-9hckj4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9hckj4.